We are live on ! Find out more
TSVT

2seventy bio
TSVT

Delisted

TSVT was delisted on the 13th of May, 2025.

Back to rankings

146 hedge funds and large institutions have $508M invested in 2seventy bio in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 21 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 21

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

80% more call options, than puts

Call options by funds: $656K | Put options by funds: $364K

60% more capital invested

Capital invested by funds: $317M → $508M (+$191M)

20% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 25

4% more funds holding

Funds holding: 141 → 146 (+5)

Holders
146
Holders Change
+5
Holders Change %
+3.55%
% of All Funds
2.33%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
30
Increased
55
Reduced
21
Closed
25
Calls
$656K
Puts
$364K
Net Calls
+$292K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kynam Capital Management
New Jersey
+$42.7M
2
Citadel Advisors
Citadel Advisors
Florida
+$24.1M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$16.4M
4
O
OrbiMed
New York
+$15.4M
5
Morgan Stanley
Morgan Stanley
New York
+$10.9M

Top Sellers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
-$11.2M
2
EC
EcoR1 Capital
California
-$10.7M
3
SVCM
Saturn V Capital Management
Texas
-$5.86M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.28M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCA
126
Column Capital Advisors
Indiana
$1.43K – – –
Northwestern Mutual Wealth Management
127
Northwestern Mutual Wealth Management
Wisconsin
$1.34K +$835 +73 +126%
PP
128
PFS Partners
New Jersey
$1.15K – – –
SPIA
129
Steward Partners Investment Advisory
New York
$1.08K – – –
HWM
130
HighMark Wealth Management
Minnesota
$775 – – –
BC
131
Barrett & Company
Rhode Island
$673 – – –
BWAM
132
Boyd Watterson Asset Management
Ohio
$418 – – –
TC
133
Truvestments Capital
Florida
$418 – – –
BCWM
134
Bartlett & Co Wealth Management
Ohio
$337 – – –
PFBT
135
Parkside Financial Bank & Trust
Missouri
$337 – – –
S
136
SignatureFD
Georgia
$275 +$309 +27 New
FFA
137
Fairfield Financial Advisors
Massachusetts
$198 – – –
GRP
138
Global Retirement Partners
California
$151 – – –
LFG
139
Larson Financial Group
Missouri
$82 – – –
TFM
140
TFC Financial Management
Massachusetts
$41 – – –
PA
141
Parallel Advisors
California
$31 – – –
LSA
142
Leonteq Securities AG
Switzerland
$10 – – –
MAP
143
Madison Avenue Partners
New York
– -$11.2M -1,199,832 Closed
EC
144
EcoR1 Capital
California
– -$10.7M -1,143,494 Closed
RCMNY
145
Rubric Capital Management (New York)
New York
– -$2.48M -265,000 Closed
PVI
146
Pura Vida Investments
New York
– -$2.35M -251,309 Closed
Man Group
147
Man Group
United Kingdom
– -$745K -79,504 Closed
Qube Research & Technologies (QRT)
148
Qube Research & Technologies (QRT)
United Kingdom
– -$477K -50,878 Closed
LNWWM
149
Laird Norton Wetherby Wealth Management
California
– -$288K -30,783 Closed
Walleye Capital
150
Walleye Capital
New York
– -$287K -30,671 Closed
3 4 5
6
7

TSVT Hedge Fund Activity: Q1 2023 in Review

146 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q1 2023, worth a combined $508M — up 60% from $317M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new TSVT positions and 25 closed out — a net gain of 5 holders — while 55 added to existing stakes and 21 trimmed.

The largest buyer was Kynam Capital Management, opening a new position worth an estimated $42.7M. The largest seller was Madison Avenue Partners, exiting entirely with an estimated $11.2M sold.

  • 146 institutional investors held 2seventy bio (TSVT) as of Q1 2023, up from 141 in Q4 2022.
  • Funds reported $508M of 2seventy bio stock for Q1 2023, up 60% quarter-over-quarter.
  • 30 funds opened new 2seventy bio positions in Q1 2023 and 25 closed out, a net change of +5 holders.
  • The largest 2seventy bio buyer in Q1 2023 was Kynam Capital Management, an estimated $42.7M added.
  • The largest 2seventy bio seller in Q1 2023 was Madison Avenue Partners, an estimated $11.2M sold.

Based on aggregated 13F filings for Q1 2023.